Search

Search Results

• Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients

  G. Mykhalchyshyn

  254-260

  2020-11-30
• Predictors of NAFLD rapidly progression in type 2 diabetes patients

  G. Mykhalchyshyn

  230-236

  2020-10-30
• The value of polymorphism + 3725G / C TLR4 gene as a marker of liver fibrosis progression in patients with chronic hepatitis C

  T. I. Bevz, D. F. Kyrychenko, G. A. Martynyuk

  328-336

  2019-10-30
• Non-invasive diagnostic methods of the liver fibrosis in patients with overweigh and obesity

  Nadiia Gavryliuk, Ihor Hospodarskyy, Oksana Prokopchuk, Olga Namisniak, Mykhailo Havrylyuk

  239-245

  2021-03-31
• Assessment of severity of cystic fibrosis in children depending on the vitamin D status

  Veronika Dudnyk, Valeriia Demianyshyna

  561-568

  2020-09-22
• Тhe role of the internal use of mineral water in the complex treatment of patients with chronic viral hepatitis C with concomitant non-alcoholic fatty liver disease

  Anna Izha

  226-235

  2020-01-31
• Механизмы, клиническая значимость и взаимоотношение тканевого фиброза и фибрилляции предсердий = Mechanisms, clinical significance and relationship of tissue fibrosis and atrial fibrillation = Механізми, клінічна значущість та взаємовідношення тканинного фіброзу і фібриляції передсердь

  A. I. Gozhenko, E. M. Levchenko, V. V. Goriachyi, A. V. Goriachyi

  520-536

  2017-02-10
• Clinical and psychopathological features of the course and outcome of the first psychotic episode.

  Yuri Bazhora, Valentyn Gudz, Valentina Mozgova, Kateryna Usychenko, Nikol Shvets

  279-286

  2023-11-30
• Ultrasonographic characteristics of morphometric and hemodynamic parameters of the liver and spleen in pediatric patients with chronic viral hepatitis B and C

  Y. Demchyshyn, I. Nezgoda, S. Poprotska, A. Asaulenko

  201-206

  2021-11-30
• Physical activity in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a review of evidence, mechanisms, and practical clinical recommendations

  Maciej Wojewódzki, Małgorzata Styczyńska, Alicja Cyrzan, Jakub Zalewski, Adam Zysk, Mateusz Ząbek, Martyna Iwanowska, Beata Flis, Adrian Goss, Bartosz Fronczak

  69596

  2026-03-12
• Possible Strategies for the Implementation of who Program on the Elimination of Hepatitis C in Ukraine by 2030

  I. Zaytsev, V. Potii, V. Kiriienko

  324-335

  2018-06-29
• The role of nursing staff in the nutritional therapy of a child with cystic fibrosis

  Iwona Czerwińska Pawluk, Elwira Paula Pawluk, Angelo Daniel Szymaszek, Walery Zukow

  170-177

  2019-03-11
• Comparative effectiveness of anti-fibrosis treatment in patients after HCV infection and in patients with non-alcoholic fatty liver disease (NAFLD)

  Nadiia Gavryliuk, Ihor Hospodarskyy, Oksana Prokopchuk, Olha Krekhovska-Lepiavko, Borys Lokay, Mykhailo Havrylyuk

  222-229

  2021-02-26
• IgG4-Related Disease: The Importance of Early Diagnosis in Clinical Practice

  Magdalena Zawadzka, Karolina Gwóźdź, Marta Drozdowska, Aleksandra Natalia Bystros, Emilia Borychowska, Michalina Czudowska, Zofia Aneta Mierzejewska, Aleksandra Ocimek, Klaudia Kurzątkowska, Dominika Marszałek

  67363

  2025-12-22
• A Role of Physical Activity in Patients with Systemic Sclerosis – a literature review

  Izabela Staniszewska

  51095

  2024-05-17
• The Role of Diet and Nutrition in Heart Failure Care

  Mateusz Kasprzak, Kacper Godyń-Müller, Michał Grześkowiak, Hanna Pelant, Martin Zeigner, Joanna Błaszczyk, Bartosz Kulak, Michał Brzeziński, Zuzanna Majchrzak, Klaudia Pierzyńska

  72672

  2026-06-23
• The role of chemokines in liver disease

  Klaudia Sapuła, Jakub Gołacki, Aleksandra Marczak, Michalina Hordejuk, Klaudyna Iwaszko-Sochal

  493-503

  2022-07-14
• The Skin as a Window to Diabetes Mellitus: Manifestations, Complications and Clinical Insights

  Aleksandra Kutaj, Zuzanna Adamowicz

  57533

  2025-02-04